WEBINAR: Anchored Protein Kinase-A (PKA) as Gatekeeper for Connexin-43 Gap Junction

Speaker
  • Senior Researcher at Inserm UMR-S 1180 (CRCN)
    Biography
      Guillaume Pidoux completed his PhD at University Paris Descartes (Paris, France) in 2006 and did a postdoctoral fellowship at the Nordic EMBL, NCMM-University of Oslo (Oslo, Norway) in 2010. In 2012, he was recruited as a senior researcher at Inserm (French National Institute for Health and Medical Research). He is interested in the spatiotemporal regulation of cAMP signaling in physiological and pathophysiological conditions. He has recently established a small group at Inserm UMR-S 1180, which focuses on understanding the direct role of A-Kinase Anchoring Proteins (AKAPs) and Protein Kinase-A (PKA) in cardiac physiology and during the development of cardiomyopathies. With his cell biology and biochemistry approaches, he is paving the way to develop new therapeutic schemes aimed at improving quality of life for patients

    Abstract

    Anchored Protein Kinase-A (PKA) bound to A-Kinase Anchoring Protein (AKAP) mediates the effects of localized increases in cAMP in defined subcellular microdomains and retains the specificity in cAMP–PKA signaling to distinct extracellular stimuli. Gap junctions are pores between adjacent cells constituted by connexin (Cxs) proteins that provide a means of communication, electrical impulse propagation, and transfer of small molecules. One of the most widely and highly expressed Cxs is Cx43, which was shown to be regulated through phosphorylation by several kinases including PKA. Ezrin is a membrane-associated protein that can serve as an AKAP and hold an anchored pool of PKA. We found PKA to be part of a macromolecular signaling complex with ezrin and gap junction protein Cx43 that provides cAMP-mediated control of gap junction communication. We established that an inhibition of PKA activity or disruption of the ezrin–Cx43 interaction abolished PKA-dependent phosphorylation of Cx43 as well as gap junction communication. In vitro studies using peptide arrays, together with mass spectrometry, pointed to serine 369 and 373 of Cx43 as the major PKA phosphorylation sites. A combination of knockdown and reconstitution experiments and gap-FLIP assays with mutant Cx43 containing single or double phosphoserine–mimicking amino acid substitutions in putative PKA phosphorylation sites demonstrated that phosphorylation of S369 and S373 mediated gap junction communication. We propose that the PKA–ezrin–Cx43 macromolecular complex regulating gap junction communication constitutes a general mechanism to control opening of Cx43 gap junctions by phosphorylation in response to cAMP signaling in various cell types (i.e., heart, liver, and placenta).


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUN 30, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 30, 2020 9:00 AM PDT
    DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources